ALS Patient Dosing Begins in SLS-005 Arm of HEALEY Platform Trial
A New Approach to M.S. Could Transform Treatment of Other Diseases
Every month counts: European ALS patients want new drugs
Amyotrophic Lateral Sclerosis (ALS): A Rare Disease More Common in EU&US, Community>Bulletin
Diagnosing ALS: It's Often a Year-Long Journey - Target ALS
Can the FDA keep the momentum going for rare disease drug approvals? - Pharmaceutical Technology
Coming together for Global ALS Awareness Day
Inside Colorado's Battle Against Rare Diseases - 5280
Rare Disease Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends
About Lou Gehrig's disease: It's rare, debilitating and deadly — and every case is unique
ALS patients could get answers from recent diagnosis of rare disease
Amyotrophic lateral sclerosis - The Lancet
Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence
The Rare Disease Translational Center at The Jackson Laboratory
History of ALS: decades of scant progress and unmet needs